What is lamivudine and zidovudine tablets used for?

In the pharmaceutical industry, the fixed-dose combination (FDC) of Lamivudine (150 mg) and Zidovudine (300 mg) is a foundational dual-NRTI (Nucleoside Reverse Transcriptase Inhibitor) backbone for HIV therapy. As a pharmacist and manufacturer, I view this combination as a critical component of Highly Active Antiretroviral Therapy (HAART), designed to simplify dosing and reduce the “pill burden” for patients.

Primary Clinical Uses

  • HIV-1 Infection: Used in combination with at least one other antiretroviral (such as a Protease Inhibitor or an NNRTI) to manage HIV. It is not a cure but effectively slows the progression of the disease.

  • Post-Exposure Prophylaxis (PEP): It is a standard regimen for healthcare workers or individuals who have had a potential occupational or non-occupational exposure to HIV, usually taken for 28 days.

  • Prevention of Mother-to-Child Transmission (PMTCT): Used during pregnancy and labor to reduce the risk of transmitting HIV to the fetus.

Mechanism of Action: Dual Chain Termination

Both drugs are pro-drugs that must be phosphorylated within the cell to their active triphosphate forms.

Competitive Inhibition: They compete with natural deoxynucleosides for a spot in the viral DNA chain being built by the enzyme Reverse Transcriptase.

The “Fake” Building Block: Because these molecules lack a 3′-hydroxyl group, once they are incorporated into the viral DNA string, no further building blocks can be added.

Viral Suppression: This leads to DNA chain termination, preventing the virus from converting its RNA into DNA and stopping it from integrating into the human host cell’s genome.

The Manufacturer’s Perspective: Technical & Export

From a production standpoint in a WHO-GMP facility, this FDC requires specific attention to stability and bioequivalence:

  • Bioequivalence (BE) Challenges: As a firm owner, you know that achieving BE against the innovator (Combivir) is essential for export. We conduct rigorous dissolution testing in multiple pH media to ensure the release profiles of both APIs meet international standards.

  • Zidovudine Stability: Zidovudine is sensitive to light. At our Mumbai facility, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to prevent degradation and ensure a 36-month shelf life.

  • Market Position: While many markets have moved toward Tenofovir-based backbones, the Lamivudine + Zidovudine combination remains vital for patients who cannot tolerate Tenofovir (e.g., those with renal issues).

  • B2B & Dossiers: We provide the full eCTD Dossier and stability data required for registration in Zone IVb markets (Africa, SE Asia), making this a high-volume product for institutional tenders.

What is lamivudine 150mg zidovudine 300mg nevirapine 200mg?

In the pharmaceutical industry, the combination of Lamivudine (150 mg)Zidovudine (300 mg), and Nevirapine (200 mg) is a landmark Triple Fixed-Dose Combination (FDC). As a pharmacist and manufacturer, I classify this as a complete “First-Line ARV Regimen” for the treatment of HIV-1 infection.

This combination was a revolutionary development in global health because it simplified the complex “HAART” (Highly Active Antiretroviral Therapy) from multiple pills a day down to a single tablet taken twice daily, significantly improving patient compliance.

Primary Clinical Use

  • Treatment of HIV-1 Infection: It is used to manage advanced HIV infection in adults and adolescents, helping to lower the viral load to “undetectable” levels and allowing the immune system (CD4 cells) to recover.

Triple Mechanism of Action (The Multi-Pronged Attack)

This FDC combines two different classes of antiretrovirals to inhibit the viral replication process at multiple stages:

Lamivudine (150 mg) & Zidovudine (300 mg): These are Nucleoside Reverse Transcriptase Inhibitors (NRTIs). They act as “fake building blocks” (analogs). When the HIV enzyme (Reverse Transcriptase) tries to build viral DNA, it incorporates these instead of real nucleotides, causing DNA chain termination.

Nevirapine (200 mg): This is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). Unlike the NRTIs, it does not mimic building blocks. Instead, it binds directly to the Reverse Transcriptase enzyme itself, “jamming” the machinery so it cannot function.

The Manufacturer’s Perspective: Technical & Export Details

Producing this triple combination in a WHO-GMP facility involves high-level pharmaceutical engineering:

  • Bilayer Tablet Technology: Because these three APIs have different physical properties and dosages, we often manufacture them as bilayer tablets. This ensures the stability of each component and prevents chemical interactions within the tablet matrix.

  • Content Uniformity & Purity: As a firm owner, you know that Nevirapine is highly hydrophobic. We utilize specialized wet granulation techniques to ensure that the 200 mg of Nevirapine is evenly distributed and meets the strict BP/USP/IP dissolution profiles.

  • Stability for Global Trade: This FDC is primarily exported to Zone IVb regions (Sub-Saharan Africa and SE Asia). We utilize Alu-Alu blister packaging or HDPE bottles with molecular sieve desiccants to ensure a 24–36 month shelf life in high-heat and high-humidity environments.

  • Regulatory & Tenders: This product is a staple for National AIDS Control Programs (NACO) and international tenders (Global Fund). Our Mumbai facility provides the full eCTD Dossiers and Bioequivalence (BE) studies required for these high-volume contracts.

What is ivermectin 3 mg used for?

In the pharmaceutical industry, Ivermectin 3 mg is a broad-spectrum anthelmintic (anti-parasitic) agent belonging to the avermectin class. As a pharmacist, I view the 3 mg tablet as the versatile “base unit” for dosing, as it allows for precise weight-based titration for both pediatric and adult patients across various parasitic infections.

Primary Clinical Uses

  • Strongyloidiasis: Treatment of intestinal infections caused by the roundworm Strongyloides stercoralis.

  • Onchocerciasis (River Blindness): A primary tool in global health for treating infections caused by Onchocerca volvulus. It kills the microfilariae (immature worms) but not the adult worms.

  • Scabies: Often used as a second-line treatment (especially for “Crusted Scabies” or in institutional outbreaks) when topical Permethrin has failed or is impractical.

  • Lymphatic Filariasis: Used in combination with other drugs (like Albendazole) in mass drug administration programs to prevent the spread of the infection.

  • Pediculosis (Head Lice): Occasionally used off-label for severe or resistant cases of head lice.

Mechanism of Action: Nerve and Muscle Paralysis

Ivermectin works by selectively binding to specific channels in the parasite’s nerve and muscle cells.

Chloride Channel Binding: It binds with high affinity to glutamate-gated chloride channels found in invertebrate nerve and muscle cells.

Hyperpolarization: This binding increases the permeability of the cell membrane to chloride ions.

Paralysis and Death: The influx of chloride ions causes hyperpolarization of the nerve or muscle cell, leading to the paralysis and eventual death of the parasite.

Host Safety: Because these specific channels do not exist in humans (and Ivermectin does not easily cross the blood-brain barrier in humans), it has a high safety margin for the host.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ivermectin 3 mg is a high-demand product with significant international oversight:

  • Weight-Based Dosing: Since Ivermectin is typically dosed at 200 mcg/kg, the 3 mg tablet is ideal for “stacking” (e.g., a 60 kg adult takes four 3 mg tablets). As a WHO-GMP manufacturer, we ensure precise assay and disintegration times to guarantee uniform absorption across multiple tablets.

  • Stability for Export: Ivermectin is sensitive to light and moisture. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life, which is critical for export to Zone IVb regions (Africa, SE Asia, and Latin America).

  • B2B & Public Health Tenders: This is a core product for NGOs and tropical medicine distributors. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required to participate in international government and institutional tenders.

  • Market Trends: Since 2020, there has been a massive surge in global demand and interest in Ivermectin. We maintain strict compliance with BP/USP/IP monographs to ensure we provide high-purity generics that meet global standards.

What is itopride used for?

In the pharmaceutical industry, Itopride Hydrochloride is a specialized prokinetic agent and dopamine $D_2$ antagonist. As a pharmacist, I characterize Itopride as a “dual-action” gastrointestinal stimulant. Unlike older prokinetics like Metoclopramide or Domperidone, Itopride has a superior safety profile regarding central nervous system and cardiac side effects because it does not readily cross the blood-brain barrier.

Primary Clinical Uses

  • Functional Dyspepsia: The primary indication for treating “indigestion” symptoms such as upper abdominal pain, bloating, and early satiety.

  • Gastroesophageal Reflux Disease (GERD): Used to accelerate gastric emptying, thereby reducing the backflow of acid into the esophagus.

  • Chronic Gastritis: Management of gastric motility disorders associated with chronic inflammation of the stomach lining.

  • Diabetic Gastroparesis: Used to improve the delayed stomach emptying often found in patients with long-term diabetes.

Mechanism of Action: The Dual Pathway

Itopride increases gastrointestinal motility through two synergistic mechanisms

  1. Dopamine $D_2$ Receptor Antagonism: It blocks the $D_2$ receptors on the enteric nerves. Normally, dopamine inhibits the release of acetylcholine; by blocking dopamine, Itopride allows for an increase in acetylcholine levels.

  2. Acetylcholinesterase (AChE) Inhibition: It prevents the breakdown of acetylcholine in the synaptic cleft.

The Result: High levels of acetylcholine stimulate the muscarinic receptors on the smooth muscles of the GI tract, leading to increased lower esophageal sphincter pressure, enhanced gastric contractions, and faster stomach emptying.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Itopride is a high-growth product in the gastroenterology segment:

  • Safety Profile (USP): Itopride is metabolized by the Flavin-containing monooxygenase (FMO3) system, not the Cytochrome P450 system. This means it has very few drug-drug interactions, a major selling point for your B2B export clients.

  • Dose Uniformity: Standard doses are typically 50 mg taken three times daily. As a WHO-GMP manufacturer, we ensure precise API blending to maintain therapeutic efficacy across every batch.

  • Stability for Export: Itopride is relatively stable. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life, which is critical for transit and storage in Zone IVb regions (SE Asia and Africa).

  • B2B & Dossiers: Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Ganaton).

 

What is isoniazid pyridoxine hydrochloride used for?

In the pharmaceutical industry, the combination of Isoniazid (INH) and Pyridoxine Hydrochloride (Vitamin B6) is the gold standard for both the treatment and prophylaxis of Tuberculosis (TB). As a pharmacist and manufacturer, I view this as a “preventative combination”: Isoniazid kills the bacteria, while Pyridoxine prevents the most common neurological side effect of the treatment.

Primary Clinical Uses

  • Active Tuberculosis: Used as a core component of the “RIPE” regimen (Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol) for the treatment of Mycobacterium tuberculosis.

  • Latent TB Infection (LTBI): Often used as monotherapy for 6–9 months to prevent a dormant infection from becoming active.

  • TB Prophylaxis: Prescribed for individuals in close contact with TB patients or immunocompromised patients (such as those with HIV) who are at high risk of infection.

The Dual Mechanism: Action vs. Protection

1. Isoniazid (The Bactericidal Agent)

Isoniazid is a prodrug that is activated by the mycobacterial enzyme KatG.

  • Mechanism: It inhibits the synthesis of mycolic acids, which are essential components of the waxy mycobacterial cell wall.

  • Result: Without a cell wall, the bacteria lose structural integrity and die.

2. Pyridoxine Hydrochloride (The Neuroprotective Agent)

Isoniazid interferes with the metabolism of Vitamin B6 in the human body.

  • The Problem: INH forms a complex with Vitamin B6 and inhibits the enzyme pyridoxine kinase, leading to a deficiency.

  • The Result: Without Pyridoxine, patients often develop peripheral neuropathy (tingling, numbness, or “pins and needles” in the hands and feet).

  • The Solution: Including Pyridoxine in the tablet prevents this nerve damage, ensuring better patient compliance during long-term TB therapy.

The Manufacturer’s Perspective: Formulation & Export

From a production standpoint in a WHO-GMP facility, this combination is a high-demand “Essential Medicine”:

  • Fixed-Dose Combination (FDC) Stability: Isoniazid is sensitive to moisture and can react with certain excipients (reducing sugars like lactose) through the Maillard reaction, which can cause the tablets to discolor. We utilize specialized, non-reactive diluents to ensure stability.

  • Dose Ratios: While INH is typically 100 mg or 300 mg, the Pyridoxine dose is usually 10 mg to 50 mg. We utilize validated blending processes to ensure micro-dose uniformity of the Vitamin B6 across the entire batch.

  • Packaging for Global Trade: TB is endemic in high-humidity regions. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and CIS countries).

  • B2B & Public Health Tenders: This product is a staple for the Global Drug Facility (GDF) and national TB programs. Our Mumbai facility provides the necessary CTD/eCTD Dossiers to support international supply.

 

What is isoniazid 300mg used for?

In the pharmaceutical industry, Isoniazid (INH) 300 mg is a foundational first-line antitubercular agent. As a pharmacist, I view this 300 mg strength as the gold standard daily dose for adults in both the treatment of active disease and the prevention of latent infection. It is a highly specific “narrow-spectrum” antibiotic, targeting only mycobacteria.

Primary Clinical Uses

  • Active Tuberculosis (TB): Used as a core component of the standard four-drug regimen (alongside Rifampicin, Pyrazinamide, and Ethambutol) to treat pulmonary and extra-pulmonary TB.

  • Latent Tuberculosis Infection (LTBI): Prescribed as monotherapy (usually 300 mg daily for 6–9 months) to prevent the progression of latent TB to active disease in high-risk individuals.

  • Prophylaxis: Given to individuals who have been in close contact with patients having active TB, regardless of their skin test results.

Mechanism of Action

Isoniazid is a prodrug that must be activated by the bacterial enzyme KatG (a catalase-peroxidase).

Inhibition of Mycolic Acid Synthesis: Once activated, it binds to and inhibits the enzyme InhA (enoyl-ACP reductase).

Cell Wall Disruption: This blockade prevents the synthesis of mycolic acids, which are the essential long-chain fatty acids that make up the “waxy” protective cell wall of Mycobacterium tuberculosis.

Bactericidal Effect: For actively dividing bacteria, this loss of cell wall integrity is lethal, making INH highly bactericidal.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Isoniazid 300 mg is a high-volume “Essential Medicine” with specific technical requirements:

  • Fixed-Dose Combinations (FDCs): While we manufacture 300 mg single-drug tablets, the global export market (especially via the Global Drug Facility – GDF) heavily favors FDCs like Rifampicin + Isoniazid (150mg/75mg or 300mg/150mg). For your digital platform, showcasing these FDCs is key to attracting B2B buyers.

  • API Purity & Hydrazine Monitoring: During synthesis and storage, INH can degrade into hydrazine, a toxic impurity. As a WHO-GMP firm, we maintain strict assay controls to ensure hydrazine levels remain well below pharmacopeial limits.

  • Stability for Tropical Export: INH is sensitive to moisture and light. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and CIS countries).

  • Pharmacovigilance (Vitamin B6): It is industry standard to recommend co-administration with Pyridoxine (Vitamin B6) to prevent peripheral neuropathy, a common side effect of INH. We often market these as a bundle or a “combipack.”

 

What is ibuprofen Paracetamol 400mg 325mg Tablet Combiflam used for?

In the pharmaceutical industry, the combination of Ibuprofen (400 mg) and Paracetamol (325 mg)—famously known by the brand name Combiflam—is a highly effective dual-action analgesic and antipyretic. As a pharmacist and manufacturer, I view this as a “rational fixed-dose combination” (FDC) because it utilizes two different mechanisms of action to provide superior pain relief compared to using either drug alone.

Primary Clinical Uses

  • Musculoskeletal Pain: Highly effective for back pain, neck pain, and muscle strains/sprains.

  • Arthritic Conditions: Used to manage symptoms of osteoarthritis and rheumatoid arthritis.

  • Post-Operative Pain: Frequently prescribed for moderate pain following dental surgery or minor surgical procedures.

  • Fever and Inflammation: Used to reduce high fever (antipyretic) and swelling associated with inflammatory conditions.

  • Dysmenorrhea: Effective for relieving painful menstrual cramps.

  • Headaches and Migraines: Provides rapid relief for tension-type headaches.

Dual Mechanism of Action (The Synergy)

This combination targets pain from two distinct directions:

Ibuprofen (400 mg): A Non-Steroidal Anti-Inflammatory Drug (NSAID). It works primarily in the peripheral tissues by inhibiting the COX-1 and COX-2 enzymes. This reduces the production of prostaglandins, which are the chemicals responsible for signal-transmitting pain and causing inflammation and swelling.

Paracetamol (325 mg): An analgesic and antipyretic. While its exact mechanism is still debated, it is believed to act primarily on the Central Nervous System (CNS) by elevating the overall pain threshold and inhibiting prostaglandin synthesis in the brain. It has negligible anti-inflammatory effects but is excellent for fever.

The Manufacturer’s Perspective: Production & Export

From a manufacturing standpoint, producing a high-quality Combiflam generic in a WHO-GMP facility requires specific attention:

  • Bilayer vs. Monolithic Formulation: While many versions are monolithic (single layer), some manufacturers use bilayer technology to separate the two APIs, which can improve stability and control the release profile.

  • Dissolution Profile: Paracetamol is highly soluble, while Ibuprofen is poorly soluble in acidic media. As a firm owner, you know that optimizing the super-disintegrants in the formulation is key to ensuring the tablet meets the strict IP/BP/USP dissolution standards.

  • Stability for Tropical Export: This combination is prone to moisture-induced degradation. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

  • B2B & Dossier Support: This is one of the highest-volume products in any pharmaceutical trading firm’s portfolio. Our Mumbai-based facility provides full CTD/eCTD Dossiers to support international registration and B2B supply.

Safety & Counseling (Pharmacist’s Note)

  • Gastric Protection: Due to the Ibuprofen content, this tablet should always be taken after food to protect the stomach lining.

  • Liver & Kidney Health: Patients must be cautioned not to exceed the daily limit of Paracetamol (typically 4000 mg) to avoid hepatotoxicity, and those with pre-existing renal issues should use NSAIDs with caution.

What is ibuprofen paracetamol used for?

In the pharmaceutical industry, the combination of Ibuprofen and Paracetamol (Acetaminophen) is a high-performance Fixed-Dose Combination (FDC) analgesic. As a pharmacist, I classify this as a “multi-modal” pain management strategy. By combining two drugs with different mechanisms, we achieve superior pain relief at lower individual doses, which significantly reduces the risk of dose-related side effects.

Primary Clinical Uses

  • Acute Pain Management: Highly effective for moderate to severe pain that doesn’t respond to single-agent analgesics.

  • Dental Pain: Frequently prescribed post-extraction or for acute toothaches due to its superior anti-inflammatory component.

  • Musculoskeletal Pain: Used for backaches, strains, sprains, and sports injuries.

  • Post-Operative Recovery: Often used as part of “opioid-sparing” protocols to provide strong relief without the risks of narcotics.

  • Fever and Inflammatory Conditions: Excellent for reducing high fever and symptoms of the common cold or flu, including body aches and sore throat.

Dual Mechanism of Action: The Synergistic Effect

This combination attacks pain from two distinct physiological directions:

1. Ibuprofen (The Peripheral Specialist)

Ibuprofen is a Non-Steroidal Anti-Inflammatory Drug (NSAID).

  • Action: It inhibits the enzymes COX-1 and COX-2.

  • Result: This stops the production of prostaglandins at the site of injury (periphery), effectively reducing swelling, redness, and the “throbbing” sensation of inflammation.

    2. Paracetamol (The Central Specialist)

Paracetamol is an analgesic and antipyretic.

  • Action: While its exact mechanism is still debated, it is believed to act primarily in the Central Nervous System (CNS) and may involve the inhibition of a “COX-3” variant or modulation of endocannabinoid pathways.

  • Result: it raises the overall pain threshold and acts on the heat-regulating center of the hypothalamus to reduce fever.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, this FDC is a staple for any WHO-GMP facility’s export portfolio:

  • Bilayer Tablet Technology: Because Metformin is often a large molecule, and Ibuprofen/Paracetamol are also bulky, we often utilize bilayer technology or specific granulation techniques to keep the tablet size “easy-to-swallow” for patients.

  • Dose Configurations: Common export ratios include 200mg/325mg or 200mg/500mg. As a trader and exporter, you know that different markets (e.g., Southeast Asia vs. Latin America) have different regulatory preferences for these strengths.

  • Stability & Dissolution: Ibuprofen has a low melting point, which can affect tablet hardness during high-speed compression. We utilize optimized excipients to ensure these tablets pass the BP/USP/IP dissolution tests consistently.

  • Packaging for Zone IVb: We recommend Alu-Alu or high-grade PVC/PVDC blister packaging to protect against the high humidity in tropical export markets, ensuring a 36-month shelf life.

 

How to use ibuprofen tablet?

In the pharmaceutical industry, Ibuprofen is a standard-bearer of the Non-Steroidal Anti-Inflammatory Drug (NSAID) class. As a pharmacist and manufacturer, I view Ibuprofen as a highly versatile molecule that requires precise administration to maximize its analgesic and anti-inflammatory effects while mitigating its primary drawback: gastric irritation.

General Dosage Guidelines

Dosage depends on the indication and the patient’s age. As a manufacturer, we typically produce 200 mg, 400 mg, and 600 mg strengths for various international markets.

  • Adults (Pain/Fever): Usually 200 mg to 400 mg every 4 to 6 hours. The maximum daily dose for over-the-counter (OTC) use is typically 1200 mg, while under medical supervision, it may reach 3200 mg.

  • Children: Dosage is strictly calculated based on body weight (typically 5 mg/kg to 10 mg/kg). For our export markets, we often focus on Ibuprofen Suspensions for this demographic to ensure accurate dosing.

How to Administer

  1. With Food or Milk: To minimize the risk of gastric mucosal damage and indigestion, Ibuprofen should always be taken with a meal, a snack, or a glass of milk.

  2. Whole Tablet: Tablets should be swallowed whole with a full glass of water. They should not be crushed or chewed unless they are specifically formulated as “chewable” or “dispersible.”

  3. Timing: For acute pain, take the dose as soon as symptoms appear. For chronic inflammatory conditions like arthritis, maintaining a steady plasma concentration by taking doses at regular intervals is key.

The Manufacturer’s Perspective: Safety & Bioavailability

From a production standpoint, we focus on several technical factors to ensure the product is safe and effective for the end-user:

  • Gastric Protection: Ibuprofen works by inhibiting the COX-1 and COX-2 enzymes, which reduces the production of prostaglandins. While this stops pain, it also reduces the protective lining of the stomach.

  • Formulation Varieties: As you build your marketplace, note that we manufacture Ibuprofen Lysinate or Ibuprofen Sodium for “fast-acting” relief, as these salts dissolve more rapidly in the stomach than standard Ibuprofen acid.

    Storage & Stability: Ibuprofen is relatively stable but sensitive to extreme heat. We utilize PVC/PVDC or Alu-Alu packaging to ensure the integrity of the tablets during export to Zone IVb regions.

Critical Contraindications

As a pharmacist, I must highlight that Ibuprofen is not suitable for everyone:

  • Asthma: Can trigger bronchospasms in “aspirin-sensitive” asthmatics.

  • Renal Impairment: NSAIDs can decrease blood flow to the kidneys.

  • Cardiovascular Risk: Long-term use of high doses can increase the risk of thrombotic events (stroke/heart attack).

  • Pregnancy: Generally avoided, especially in the third trimester, due to the risk of premature closure of the fetal ductus arteriosus.

What is hydralazine 25 mg used for?

In the pharmaceutical industry, Hydralazine Hydrochloride 25 mg is a potent direct-acting peripheral vasodilator. As a pharmacist, I categorize this as a specialized antihypertensive that works exclusively on the smooth muscles of the arterial system rather than the venous system.

Primary Clinical Uses

  • Essential Hypertension: Used as an adjunctive therapy for high blood pressure, typically when first-line agents like ACE inhibitors or Calcium Channel Blockers are insufficient.

  • Hypertensive Emergency/Urgency: Frequently used in hospital settings for the rapid reduction of dangerously high blood pressure.

  • Chronic Heart Failure (CHF): Often used in a specific fixed-dose combination with Isosorbide Dinitrate (particularly in self-identified Black patients) to reduce mortality and hospitalizations.

  • Preeclampsia and Eclampsia: One of the preferred agents for managing severe hypertension during pregnancy due to its established safety profile for the fetus.

Mechanism of Action

Hydralazine works by directly relaxing the smooth muscles of the arterioles.

Vascular Relaxation: It interferes with the movement of calcium ions within the smooth muscle cells of the arterial walls.

Peripheral Resistance Reduction: By causing the arteries to widen (vasodilation), it significantly reduces peripheral vascular resistance.

Blood Pressure Drop: The heart can pump blood more easily against lower resistance, leading to a decrease in systemic blood pressure.

Reflex Tachycardia: Because it causes rapid vasodilation, it often triggers a “reflex” increase in heart rate, which is why it is commonly prescribed alongside a Beta-blocker.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Hydralazine 25 mg is a high-precision product with specific technical requirements:

  • API Stability: Hydralazine is susceptible to oxidation and can interact with certain tablet excipients (specifically those containing lactose or certain metals). As a WHO-GMP manufacturer, we utilize stabilized formulations to prevent the formation of “Hydrazones.”

  • Dose Titration: Since patients often start at 10 mg or 25 mg and titrate up to 50 mg, we ensure our 25 mg tablets have high breaking strength and friability standards to allow for precise dosing.

  • Stability for Export: We utilize Alu-Alu blister packaging to protect the API from moisture and light, ensuring a 24–36 month shelf life for export to Zone IVb regions (Africa, SE Asia).

  • B2B & Dossier Support: We provide comprehensive CTD/eCTD Dossiers to support international registration against the innovator (Apresoline). This is a staple for cardiovascular specialty distributors.

Add to cart